52
Views
14
CrossRef citations to date
0
Altmetric
Case Report

Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report

, , , , &
Pages 1521-1525 | Published online: 13 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Min Jin, Jun Cai, Xuan Wang, Tao Zhang & Yingchao Zhao. (2018) Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature review. Cancer Biology & Therapy 19:12, pages 1088-1092.
Read now
Jin-min Xue, Manirakiza Astère, Mao-xi Zhong, Han Lin, Jin Shen & Yu-xi Zhu. (2018) Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis. OncoTargets and Therapy 11, pages 6119-6128.
Read now
Anji Li, Shuai Sun, Tao Song, Xi Li, Wen Cheng, Ruipin Yao, Danying Zhang, Zailong Cai, Jie Zhang, Dongxia Zhai & Chaoqin Yu. (2018) Targeted therapy and immunotherapy for platinum-refractory advanced ovarian adenosquamous carcinoma: a case report. OncoTargets and Therapy 11, pages 3705-3711.
Read now

Articles from other publishers (10)

Hang-Ping Wei, Jie Mao & Zu-Liang Hu. (2022) Successful apatinib treatment for advanced clear cell renal carcinoma as a first-line palliative treatment: A case report. World Journal of Clinical Cases 10:11, pages 3593-3600.
Crossref
Zhongyu Wang, Yake Huang, Ling Long, Li Zhou, Yan Huang, Lei Gan, Aimin Pu, Sufen Li & Rongkai Xie. (2021) Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression. Journal of Ovarian Research 14:1.
Crossref
Xiaodan Sun, Ji Li, Yizhuo Li, Shouhan Wang & Qingchang Li. (2020) Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells. Oxidative Medicine and Cellular Longevity 2020, pages 1-19.
Crossref
Lihua Chen, Xi Cheng, Wenzhi Tu, Zihao Qi, Haoran Li, Fei Liu, Yufei Yang, Zhe Zhang & Ziliang Wang. (2019) Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells. Cellular Oncology 42:5, pages 679-690.
Crossref
Jing Tang, Xu Yong Li, Jing Bo Liang, De Wu, Li Peng & Xiaobing Li. (2019) Apatinib Plus Chemotherapy Shows Clinical Activity in Advanced NSCLC: A Retrospective Study. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 27:6, pages 635-641.
Crossref
Zedong Du, Yanxin Yu, Dajun Wu, Guangyu Zhang, Yang Wang, Liang He & RongQin Meng. (2018) Apatinib for salvage treatment of advanced malignant pleural mesothelioma. Medicine 97:45, pages e13105.
Crossref
Xiaofeng Li, Yueming He, Jinfeng Zhu, Hongxia Pang, Yongwei Lin & Jinyang Zheng. (2018) Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review. Oncotarget 9:72, pages 33734-33738.
Crossref
Huiting Sun, Min Xiao, Sufen Liu & Ruxia Shi. (2018) Use of apatinib combined with pemetrexed for advanced ovarian cancer. Medicine 97:27, pages e11036.
Crossref
Xiaoyun Liu, Yifan Zhang, Qian Chen, Yan Zhan, Quanren Wang, Chaoying Hu, Chen Yu, Zitao Guo, Xiaoyan Chen & Dafang Zhong. (2017) Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole. The Journal of Clinical Pharmacology 58:3, pages 347-356.
Crossref
. (2017) Apatinib. Reactions Weekly 1648:1, pages 46-46.
Crossref